| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Escherichia coli (WY100) |
- |
- |
3 － ? |
Ampicillin (Omnipen)  |
674 |
| Escherichia coli (WY100) |
- |
- |
3 － ? |
Cefoxitin (Mefoxin) |
674 |
| Escherichia coli (X580) |
- |
- |
6.25 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1049 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
4 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
8 － ? |
A-thanatin |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
8 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
8 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
≤25 － ? |
Imipenem |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
>256 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (XJ74283 + MDR) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
2 － ? |
Imipenem |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
2 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
4 － ? |
A-thanatin |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
>256 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
>256 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (XJ75297 + ESBL-KP) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
16 － ? |
A-thanatin |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
≤25 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
≤25 － ? |
Imipenem |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
64 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
>256 － ? |
Ampicillin (Omnipen) |
1089 |
| Escherichia coli (XJ75315 + MDR-PA) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1089 |
| Escherichia coli (XL1 blue/ pET9d) |
- |
- |
12 － ? |
Gentamicin C1A |
1005 |
| Escherichia coli (XL1 blue/ pET9d) |
- |
- |
12 － ? |
NB45 |
1005 |
| Escherichia coli (XL1) |
- |
- |
0.06 － ? |
Aztreonam (Azactam) |
1449 |
| Escherichia coli (XL1) |
- |
- |
0.06 － ? |
Cefepime (Maxipime) |
1449 |